-
This subset analysis from a larger prospective, multicenter HIV-HCV coinfection treatment trial found that patients receiving highly active antiretroviral therapy (HAART) in combination with pegylated interferon alfa and ribavirin for HCV were at greater risk for lactic acidosis and hyperlactatemia than those receiving HCV treatment alone.
-
In this issue: Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
-
-
Colistin (Ppolymyxin E) was isolated from bacillus colistinus 60 years ago and, during the 1960s, a new intravenous formulation (Coly-Mycin M Parenteral) became available for use in clinical practice.
-
Using liquid medium with a commercial air sampler, air was sampled at varying distances from 19 patients admitted to the hospital with Pneumocystis pneumonia. Samples were examined and DNA quantified using a real-time PCR assay targeting the large subunit ribosomal RNA gene.
-
Nasal carriage of mr-cons was prospectively investigated in 291 adults upon hospital admission.
-
-
According to many stakeholders of the hospital-based inpatient psychiatric services (HBIPS) core measure set, it's been a long time coming.
-
Probably the most incendiary change in the Centers for Medicare & Medicaid Services' inpatient prospective payment system (IPPS) rule for 2011 is an ultimate reduction in hospital payments.
-
Chief medical officer and executive vice president at Golden, CO-based HealthGrades, Samantha Collier, MD, MBA, is changing hats and moving inhouse.
